Zoetis Inc. (ZTS) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
10 SYLVAN WAY PARSIPPANY, NJ 07054 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Restricted cash and investments | 2 | 2 | 4 | 3 | 2 | 2 | |||
| Receivables | 1,395 | 1,362 | 1,286 | 1,180 | 1,061 | 1,123 | |||
| Inventory, net of allowances, customer advances and progress billings | 2,306 | 2,564 | 2,345 | 1,923 | 1,628 | 1,410 | |||
| Inventory | 2,306 | 2,564 | 2,345 | 1,923 | 1,628 | 1,410 | |||
| Other current assets | 377 | 434 | 365 | 389 | 366 | 318 | |||
| Other undisclosed current assets | 1,906 | 1,981 | 3,506 | 3,435 | 3,554 | 1,895 | |||
| Total current assets: | 5,986 | 6,343 | 7,506 | 6,930 | 6,611 | 4,748 | |||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 219 | 230 | 220 | 181 | 192 | 189 | |||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 3,391 | 3,204 | 2,753 | 2,422 | 2,202 | 1,940 | |||
| Intangible asset, including goodwill, after accumulated amortization | 3,851 | 4,097 | 4,126 | 4,156 | 4,404 | 4,482 | |||
| Goodwill | 2,724 | 2,759 | 2,746 | 2,682 | 2,694 | 2,592 | |||
| Intangible asset, excluding goodwill, after accumulated amortization | 1,127 | 1,338 | 1,380 | 1,474 | 1,710 | 1,890 | |||
| Deferred income tax assets | 540 | 206 | 173 | 100 | 94 | ||||
| Other noncurrent assets | 250 | 206 | 147 | 111 | 106 | 98 | |||
| Other undisclosed noncurrent assets | 88 | ||||||||
| Total noncurrent assets: | 8,251 | 7,943 | 7,419 | 6,970 | 6,998 | 6,797 | |||
| TOTAL ASSETS: | 14,237 | 14,286 | 14,925 | 13,900 | 13,609 | 11,545 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 1,179 | 1,094 | 1,087 | 1,730 | 1,473 | 1,251 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | ✕ | 154 | 119 | 95 | ||
| Taxes payable | ✕ | ✕ | ✕ | ✕ | 38 | 46 | 36 | ||
| Employee-related liabilities | ✕ | ✕ | ✕ | ✕ | 392 | 295 | 276 | ||
| Accounts payable | 433 | 411 | 405 | 436 | 457 | 301 | |||
| Accrued liabilities | 746 | 683 | 682 | 710 | 556 | 543 | |||
| Debt | 1,351 | 4 | 1,352 | 604 | 500 | ||||
| Other liabilities | 125 | 102 | 97 | 67 | 93 | 55 | |||
| Other undisclosed current liabilities | 757 | 689 | 631 | ||||||
| Total current liabilities: | 3,412 | 1,889 | 3,167 | 1,797 | 2,170 | 1,806 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 5,220 | 6,564 | 6,552 | 6,743 | 6,758 | 6,111 | |||
| Long-term debt, excluding current maturities | 5,220 | 6,564 | 6,552 | 6,592 | 6,595 | 5,947 | |||
| Liabilities, other than long-term debt | 835 | 842 | 803 | 816 | 908 | 509 | |||
| Accounts payable and accrued liabilities | 272 | 271 | 258 | 257 | 260 | 257 | |||
| Asset retirement obligations | 23 | ||||||||
| Deferred income tax liabilities | 167 | 146 | 142 | 320 | 378 | ||||
| Other liabilities | 222 | 237 | 217 | 239 | 270 | 229 | |||
| Operating lease, liability | 174 | 188 | 186 | 151 | 163 | 164 | |||
| Other undisclosed noncurrent liabilities | 411 | ||||||||
| Total noncurrent liabilities: | 6,055 | 7,406 | 7,355 | 7,559 | 7,666 | 7,031 | |||
| Total liabilities: | 9,467 | 9,295 | 10,522 | 9,356 | 9,836 | 8,837 | |||
| Equity | |||||||||
| Equity, attributable to parent | 4,770 | 4,997 | 4,405 | 4,543 | 3,769 | 2,708 | |||
| Common stock | 5 | 5 | 5 | 5 | 5 | 5 | |||
| Treasury stock, value | (7,445) | (5,597) | (4,539) | (2,952) | (2,230) | (2,042) | |||
| Additional paid in capital | 1,182 | 1,133 | 1,088 | 1,068 | 1,065 | 1,044 | |||
| Accumulated other comprehensive loss | (940) | (839) | (817) | (764) | (730) | (726) | |||
| Retained earnings | 11,968 | 10,295 | 8,668 | 7,186 | 5,659 | 4,427 | |||
| Equity, attributable to noncontrolling interest | (6) | (2) | 1 | 4 | |||||
| Total equity: | 4,770 | 4,991 | 4,403 | 4,544 | 3,773 | 2,708 | |||
| TOTAL LIABILITIES AND EQUITY: | 14,237 | 14,286 | 14,925 | 13,900 | 13,609 | 11,545 | |||
Income Statement (P&L) ($ in millions)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 9,256 | 8,544 | 8,080 | 7,776 | 6,675 | 6,260 | ||
| Cost of revenue (Cost of Product and Service Sold) | (2,719) | (2,561) | (2,454) | (2,303) | (2,057) | (1,992) | ||
| Gross profit: | 6,537 | 5,983 | 5,626 | 5,473 | 4,618 | 4,268 | ||
| Operating expenses | (3,004) | (2,765) | (2,548) | (2,509) | (2,189) | (2,095) | ||
| Operating income: | 3,533 | 3,218 | 3,078 | 2,964 | 2,429 | 2,173 | ||
| Nonoperating income (expense) | 19 | 159 | (40) | (48) | (17) | 57 | ||
| Investment income, nonoperating | 5 | 37 | 4 | 10 | 12 | 16 | ||
| Loss, foreign currency transaction, before tax | (50) | (47) | (62) | (27) | (21) | (16) | ||
| Other nonoperating income (expense) | (4) | (1) | 14 | (4) | (5) | |||
| Interest and debt expense | (239) | (221) | (224) | (231) | (223) | |||
| Income from continuing operations before equity method investments, income taxes: | 3,552 | 3,138 | 2,817 | 2,692 | 2,181 | 2,007 | ||
| Other undisclosed loss from continuing operations before income taxes | (419) | (202) | (161) | (204) | (185) | (206) | ||
| Income from continuing operations before income taxes: | 3,133 | 2,936 | 2,656 | 2,488 | 1,996 | 1,801 | ||
| Income tax expense | (637) | (596) | (545) | (454) | (360) | (301) | ||
| Income from continuing operations: | 2,496 | 2,340 | 2,111 | 2,034 | 1,636 | 1,500 | ||
| Income before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | 2,034 | 1,636 | 1,500 | |
| Net income: | 2,496 | 2,340 | 2,111 | 2,034 | 1,636 | 1,500 | ||
| Net income (loss) attributable to noncontrolling interest | (10) | 4 | 3 | 3 | 2 | |||
| Net income available to common stockholders, diluted: | 2,486 | 2,344 | 2,114 | 2,037 | 1,638 | 1,500 | ||
Comprehensive Income ($ in millions)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 2,496 | 2,340 | 2,111 | 2,034 | 1,636 | 1,500 | ||
| Other comprehensive income (loss) | (101) | (22) | (53) | (34) | (4) | (97) | ||
| Comprehensive income: | 2,395 | 2,318 | 2,058 | 2,000 | 1,632 | 1,403 | ||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (10) | 4 | 3 | 3 | 2 | |||
| Comprehensive income, net of tax, attributable to parent: | 2,385 | 2,322 | 2,061 | 2,003 | 1,634 | 1,403 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.